✦ LIBER ✦

366 POSTER Phase I study of NGR-TNF, a novel vascular targeting agent, in patients with refractory solid tumours (EORTC 16041)

✍ Scribed by C. Van Herpen; W. Fiedler; S. Toma; S. Marreaud; H. Van Laarhoven; P. Lasch; J. Bogaerts; A. Heerschap; C. Bordignon; C. Punt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1228 Phase I study of NGR-hTNF, a vascul

✍ G. Citterio; F.G. De Braud; V. Gregorc; T.M. De Pas; C. Noberasco; S. Boselli; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase Ib study of NGR–hTNF, a selective

✍ Gregorc, V; Santoro, A; Bennicelli, E; Punt, C J A; Citterio, G; Timmer-Bonte, J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

1205 ORAL Phase I and Pharmacodynamic St

✍ P.A. Zucali; A. Santoro; M. Simonelli; F. De Vincenzo; E. Lorenzi; L. Rimassa; L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

725 POSTER A multicenter phase I study o

✍ S. Aamdal; A. Ahamad; J. Evans; W. Rasch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

1247 POSTER Phase I, Pharmacokinetics (P

✍ M. Simonelli; P.A. Zucali; R. De Sanctis; E. Lorenzi; F. De Vincenzo; L. Rimassa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

First results of a phase I and pharmacok

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB